Somewhat Favorable News Coverage Somewhat Unlikely to Impact Core Laboratories (CLB) Stock Price

Headlines about Core Laboratories (NYSE:CLB) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Core Laboratories earned a news impact score of 0.02 on Accern’s scale. Accern also gave media coverage about the oil and gas company an impact score of 46.8770959707616 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Here are some of the news stories that may have impacted Accern Sentiment’s analysis:

Get Core Laboratories alerts:

Cypress Energy Partners (CELP) vs. Core Laboratories (CLB) Head-To-Head Contrast ( Core Laboratories (CLB) Receives Average Rating of “Hold” from Brokerages ( Core Laboratories (CLB) Stock Rating Upgraded by ValuEngine ( Core Laboratories NV (CLB) Reached 12-Month High on May, 16 at $126.33 ( Increase in Demand for POC Testing to Boost the Fecal Occult Testing Market| Technavio (

Core Laboratories opened at $127.31 on Monday, Marketbeat reports. Core Laboratories has a 52-week low of $86.55 and a 52-week high of $130.34. The firm has a market cap of $5.63 billion, a PE ratio of 63.66 and a beta of 1.38. The company has a quick ratio of 1.76, a current ratio of 2.11 and a debt-to-equity ratio of 1.55.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, April 25th. The oil and gas company reported $0.57 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.57. Core Laboratories had a net margin of 13.24% and a return on equity of 62.69%. The business had revenue of $170.00 million during the quarter, compared to analyst estimates of $171.03 million. During the same quarter in the prior year, the firm earned $0.42 earnings per share. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. equities research analysts anticipate that Core Laboratories will post 2.71 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 22nd. Stockholders of record on Friday, April 27th will be issued a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 1.73%. The ex-dividend date of this dividend is Thursday, April 26th. Core Laboratories’s payout ratio is 110.00%.

Several equities research analysts recently commented on the stock. TheStreet raised shares of Core Laboratories from a “c” rating to a “b-” rating in a report on Thursday, February 1st. ValuEngine raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Wednesday, April 11th. Zacks Investment Research raised shares of Core Laboratories from a “hold” rating to a “buy” rating and set a $131.00 price target for the company in a report on Tuesday, April 17th. Citigroup boosted their price target on shares of Core Laboratories from $117.00 to $123.00 and gave the stock a “neutral” rating in a report on Monday, April 30th. Finally, Royal Bank of Canada set a $125.00 price target on shares of Core Laboratories and gave the stock a “buy” rating in a report on Tuesday, January 30th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $115.63.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.

Insider Buying and Selling by Quarter for Core Laboratories (NYSE:CLB)

Leave a Reply

Your email address will not be published. Required fields are marked *